Randomized, crossover, open-label study of the relative bioavailability and safety of FT218, a once-nightly sodium oxybate formulation: Phase 1 study in healthy volunteers

Richard Bogan, Michael J. Thorpy, John W. Winkelman, Jordan Dubow, Jennifer Gudeman, David Seiden

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized, crossover, open-label study of the relative bioavailability and safety of FT218, a once-nightly sodium oxybate formulation: Phase 1 study in healthy volunteers'. Together they form a unique fingerprint.

Medicine & Life Sciences